STEVENSON AND KORMOS, ET AL., Mechanical Carida Support
2000
JACC Vol. 37, No. 1, January 2001:340-70
References
1.
Sun B.C. Device Selection. In: Goldstein D.J., Oz M.C.
editors. Cardiac Assist Devices. Armonk, NY: Futura
2000:27-36
2.
Pennington DG, Swartz MT, Lohmann DP, McBride LR. Cardiac
assist devices. Surg Clin North Am 1998;78:691–704,
vii.
3.
Curtis J.J. Extracorporeal support: centrifugal pumps.
In: Goldstein D.J., Oz M.C. editors. Cardiac Assist
Devices. Armonk, NY: Futura 2000:215-250
4.
Jeff G.K. Extracorporeal support: the ABIOMED BVS 5000.
In: Goldstein D.J., Oz M.C. editors. Cardiac Assist
Devices. Armonk, NY: Futura 2000:235-250
5.
McBride L.R., Naunheim K.S., Fiore A.C., Moroney D.A.,
Swartz M.T. Clinical experience with 111 thoratec ventricular
assist devices. Ann Thorac Surg. 1999;67:1233-1238.
6.
Chen J.M., DeRose J.J., Slater J.P., et al. Improved
survival rates support left ventricular assist device
implantation early after myocardial infarction. J Am
Coll Cardiol. 1999;33:1903-1908.
7.
Chen J.M., Spanier T.B., Gonzalez J.J., et al. Improved
survival in patients with acute myocarditis using external
pulsatile mechanical ventricular assistance. J Heart
Lung Transplant. 1999;18:351-357.
8.
Hetzer R., Muller J., Weng Y., Wallukat G., Spiegelsberger
S., Loebe M. Cardiac recovery in dilated cardiomyopathy
by unloading with a left ventricular assist device.
Ann Thorac Surg. 1999;68:742-749.
9.
Poirier V.L. Worldwide experience with the TCI HeartMate
system: issues and future perspective. Thorac Cardiovasc
Surg. 1999;47 Suppl 2:316-320.
10.
El Banayosy A., Deng M., Loisance D.Y., et al. The European
experience of Novacor left ventricular assist (LVAS)
therapy as a bridge to transplant: a retrospective multi-centre
study. Eur J Cardiothorac Surg. 1999;15:835-841.
11.
Farrar D.J., Hill J.D., Pennington D.G., et al. Preoperative
and postoperative comparison of patients with univentricular
and biventricular support with the thoratec ventricular
assist device as a bridge to cardiac transplantation.
J Thorac Cardiovasc Surg. 1997;113:202-209.
12.
Massad M.G., Cook D.J., Schmitt S.K., et al. Factors
influencing HLA sensitization in implantable LVAD recipients.
Ann Thorac Surg. 1997;64:1120-1125.
13.
Rose E.A., Moskowitz A.J., Packer M., et al. The REMATCH
trial: rationale, design, and end points. Randomized
Evaluation of Mechanical Assistance for the Treatment
of Congestive Heart Failure. Ann Thorac Surg. 1999;67:723-730.
14.
Torrance G.W. Measurement of health state utilities
for economic appraisal. J Health Econ. 1986;5:1-30.
15.
Katz A.M. Evolving concepts of heart failure: cooling
furnace, malfunctioning pump, enlarging muscle—Part
I. J Card Fail. 1997;3:319-334.
16.
Katz A.M. Evolving concepts of heart failure: cooling
furnace, malfunctioning pump, enlarging muscle. Part
II: Hypertrophy and dilatation of the failing heart.
J Card Fail. 1998;4:67-81.
17.
Young J.B. Chronic heart failure management. In: Topol
E.J. editors. Textbook of Cardiovascular Medicine. Philadelphia,
PA: Lippincott-Raven, 1998
18.
Uretsky B.F., Young J.B., Shahidi F.E., Yellen L.G.,
Harrison M.C., Jolly M.K. Randomized study assessing
the effect of digoxin withdrawal in patients with mild
to moderate chronic congestive heart failure: results
of the PROVED trial. PROVED Investigative Group. J Am
Coll Cardiol. 1993;22:955-962.
19.
Packer M., Gheorghiade M., Young J.B., et al. Withdrawal
of digoxin from patients with chronic heart failure
treated with angiotensin-converting-enzyme inhibitors.
RADIANCE Study. N Engl J Med. 1993;329:1-7.
20.
Digitalis Investigation Group The effect of digoxin
on mortality and morbidity in patients with heart failure.
N Engl J Med. 1997;336:525-533.
21.
Richardson A., Bayliss J., Scriven A.J., Parameshwar
J., Poole-Wilson P.A., Sutton G.C. Double-blind comparison
of captopril alone against frusemide plus amiloride
in mild heart failure. Lancet. 1987;2:709-711.
22.
Parker J.D., Parker A.B., Farrell B., Parker J.O. Effects
of diuretic therapy on the development of tolerance
to nitroglycerin and exercise capacity in patients with
chronic stable angina. Circulation. 1996;93:691-696.
23.
Silverman W.A. Human Experimentation: A Guided Step
into the Unknown. Oxford: Oxford University Press, 1985
24.
Cohn J.N., Archibald D.G., Ziesche S., et al. Effect
of vasodilator therapy on mortality in chronic congestive
heart failure. Results of a Veterans’ Administration
Cooperative Study. N Engl J Med. 1986;314:1547-1552.
25.
Cohn J.N., Johnson G., Ziesche S., et al. A comparison
of enalapril with hydralazine-isosorbide dinitrate in
the treatment of chronic congestive heart failure. N
Engl J Med. 1991;325:303-310.
26.
SOLVD Investigators. Effect of enalapril on mortality
and the development of heart failure in asymptomatic
patients with reduced left ventricular ejection fractions.
N Engl J Med. 1992;327:685-691.
27.
CONSENSUS Trial Study Group. Effects of enalapril on
mortality in severe congestive heart failure. Results
of the Cooperative North Scandinavian Enalapril Survival
Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
28.
Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect
of captopril on mortality and morbidity in patients
with left ventricular dysfunction after myocardial infarction.
Results of the Survival And Ventricular Enlargement
trial. The SAVE Investigators. N Engl J Med. 1992;327:669-677.
29.
Packer M., Carver J.R., Rodeheffer R.J., et al. Effect
of oral milrinone on mortality in severe chronic heart
failure. The PROMISE Study Research Group. N Engl J
Med. 1991;325:1468-1475.
30.
Moulopoulos L.A., Topaz S.R., Kolff W.J. Extracorporeal
assistance to the circulation and intraaortic balloon
pumping. Transactions Am Soc Artif Internal Organs.
1962;8:86
31.
Masters R.G. Surgical options for the treatment of heart
failure. Boston, MA: Clure Academic Publishers, 1999
32.
Alderman E.L., Fisher L.D., Litwin P., et al. Results
of coronary artery surgery in patients with poor left
ventricular function (CASS). Circulation. 1983;68:785-795.
33.
Murphy M.L., Hultgren H.N., Detre K., Thomsen J., Takaro
T. Treatment of chronic stable angina. A preliminary
report of survival data of the randomized Veterans Administration
cooperative study. N Engl J Med. 1977;297:621-627.
34.
Varnauskas E. Twelve-year follow-up of survival in the
randomized European Coronary Surgery Study. N Engl J
Med. 1988;319:332-337.
35.
Young J.B., Kirklin J.K. Cardiomyoplasty-Skeletal Muscle
Assist Randomized Trial (C-SMART): six month results.
Circulation. 1999;100:I-514
36.
Hochman J.S., Sleeper L.A., Webb J.G., et al. Early
revascularization in acute myocardial infarction complicated
by cardiogenic shock. SHOCK Investigators. Should We
Emergently Revascularize Occluded Coronaries for Cardiogenic
Shock. N Engl J Med. 1999;341:625-634.
37.
Urban P., Stauffer J.C., Bleed D., et al. A randomized
evaluation of early revascularization to treat shock
complicating acute myocardial infarction. The (Swiss)
Multicenter Trial of Angioplasty for Shock-(S)MASH.
Eur Heart J. 1999;20:1030-1038.
38.
Stevenson L.W. When is heart failure a surgical disease?.
In: Rose E.A., Stevenson L.W. editors. Management of
End Stage Heart Failure. Philadelphia, PA: Lippincott-Raven,
1998
39.
Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek
M.M., Novick R.J. The Registry of the International
Society for Heart and Lung Transplantation: sixteenth
official report—1999. J Heart Lung Transplant.
1999;18:611-626.
40.
United Network of Organ Sharing. 1999 Annual Report
of the United States Scientific Registry of Transplant
Recipients and Organ Procurement and Transplantation
Network. Transplant Data 1989–1998. Washington
D.C., Department of Health and Human Services. Health
Resources and Services Administration, 1999.
41.
United Network of Organ Sharing. 1997 Report OPTN: Waiting
List Activity and Donor Procurement. Rockville, MD,
UNOS, Richmond, VA, and the Division of Transplantation,
Office of Special Programs, Health Resources and Services
Administration, United States Department of Health and
Human Services, 1997.
42.
Willman VL. Expert panel review of the NHLBI Total Artificial
Heart Program; http://www.nhlbi.nih.gov/resources/docs/tah-rpt.htm.
1999.
43.
Gracin N., Johnson M.R., Spokas D., et al. The use of
APACHE II scores to select candidates for left ventricular
assist device placement. Acute Physiology and Chronic
Health Evaluation. J Heart Lung Transplant. 1998;17:1017-1023.
44.
Fedullo A.J., Swinburne A.J., Wahl G.W., Bixby K.R.
APACHE II score and mortality in respiratory failure
due to cardiogenic pulmonary edema. Crit Care Med. 1988;16:1218-1221.
45.
Goldhill D.R., Sumner A. APACHE II, data accuracy and
outcome prediction. Anaesthesia. 1998;53:937-943.
46.
American Heart Association. 1999 Heart and Stroke Statistical
Update. 1999.
47.
Holmes D.R. Jr., Bates E.R., Kleiman N.S., et al. Contemporary
reperfusion therapy for cardiogenic shock: the GUSTO-I
trial experience. The GUSTO-I Investigators. Global
Utilization of Streptokinase and Tissue Plasminogen
Activator for Occluded Coronary Arteries. J Am Coll
Cardiol. 1995;26:668-674.
48.
Hochman J.S., Boland J., Sleeper L.A., et al. Current
spectrum of cardiogenic shock and effect of early revascularization
on mortality. Results of an International Registry.
SHOCK Registry Investigators. Circulation. 1995;91:873-881.
49.
Hasdai D., Holmes D.R. Jr., Califf R.M., et al. Cardiogenic
shock complicating acute myocardial infarction: predictors
of death. GUSTO Investigators. Global Utilization of
Streptokinase and Tissue-Plasminogen Activator for Occluded
Coronary Arteries. Am Heart J. 1999;138:21-31.
50.
Lewis E.F., Johnson P.A., Johnson W., et al. Heart failure
patients express strong polarity of preference for either
quality of life or survival. Circulation. 1998;98:I86
51.
Kubo SH, Stevenson LW, Miller LW, et al. Outcomes in
non-urgent patients awaiting transplantation. J Heart
Lung Transplant 2001. In Press.
52.
Moskowitz A.J., Shapiro P.A., Sollano J.A., et al. Left
ventricular assist devices as long-term therapy for
severe heart failure. Pilot study results demonstrate
feasibility of randomized trial. Circulation. 1999;100
Suppl 1:I-514
53.
Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L.,
Goin J.E., Mancini D.M. Development and prospective
validation of a clinical index to predict survival in
ambulatory patients referred for cardiac transplant
evaluation. Circulation. 1997;95:2660-2667.
54.
Lucas C, Johnson W, Hamilton MA, et al. Freedom from
congestion predicts good survival despite previous class
IV symptoms of heart failure. Am Heart J 2001. In Press.
55.
Black N., Brazier J., Fitzpatrick R., Reeves B. Health
Services Research Methods: A Guide to Better Practice.
London: BMJ Books, 1998
56.
Bourge R.C., Naftel D.C., Costanzo-Nordin M.R., et al.
Pretransplantation risk factors for death after heart
transplantation: a multiinstitutional study. The Transplant
Cardiologists Research Database Group. J Heart Lung
Transplant. 1993;12:549-562.
57.
Naccarelli G.V., Wolbrette D.L., Dell’Orfano J.T.,
Patel H.M., Luck J.C. A decade of clinical trial developments
in postmyocardial infarction, congestive heart failure,
and sustained ventricular tachyarrhythmia patients:
from CAST to AVID and beyond. Cardiac Arrhythmic Suppression
Trial. Antiarrhythmic Versus Implantable Defibrillators.
J Cardiovasc Electrophysiol. 1998;9:864-891.
58.
Pennington D.G., Reedy J.E., Swartz M.T., et al. Univentricular
versus biventricular assist device support. J Heart
Lung Transplant. 1991;10:258-263.
59.
Farrar D.J., Hill J.D., Gray L.A. Jr., Galbraith T.A.,
Chow E., Hershon J.J. Successful biventricular circulatory
support as a bridge to cardiac transplantation during
prolonged ventricular fibrillation and asystole. Circulation.
1989;80:III147-III151.
60.
Holman W.L., Roye G.D., Bourge R.C., McGiffin D.C.,
Iyer S.S., Kirklin J.K. Circulatory support for myocardial
infarction with ventricular arrhythmias. Ann Thorac
Surg. 1995;59:1230-1231.
61.
Geannopoulos C.J., Wilber D.J., Olshansky B. Control
of refractory ventricular tachycardia with biventricular
assist devices. Pacing Clin Electrophysiol. 1991;14:1432-1434.
62.
Kulick D.M., Bolman R.M. III., Salerno C.T., Bank A.J.,
Park S.J. Management of recurrent ventricular tachycardia
with ventricular assist device placement. Ann Thorac
Surg. 1998;66:571-573.
63.
Keogh A.M., Valantine H.A., Hunt S.A., et al. Impact
of proximal or midvessel discrete coronary artery stenoses
on survival after heart transplantation. J Heart Lung
Transplant. 1992;11:892-901.
64.
Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart
transplant coronary artery disease detected by coronary
angiography: a multiinstitutional study of preoperative
donor and recipient risk factors. Cardiac Transplant
Research Database. J Heart Lung Transplant. 1998;17:744-753.
65.
Wong P.M., Piamsomboon C., Mathur A., et al. Efficacy
of coronary stenting in the management of cardiac allograft
vasculopathy. Am J Cardiol. 1998;82:239-241.
66.
McGiffin D.C., Savunen T., Kirklin J.K., et al. Cardiac
transplant coronary artery disease. A multivariable
analysis of pretransplantation risk factors for disease
development and morbid events. J Thorac Cardiovasc Surg.
1995;109:1081-1088.
67.
Oz M.C., Goldstein D.J., Pepino P., et al. Screening
scale predicts patients successfully receiving long-term
implantable left ventricular assist devices. Circulation.
1995;92:II169-II173.
68.
Thoratec VAD Voluntary Registry. Pleasanton, CA, Thoratec
Laboratories Corporation, 2000.
69.
Thermocardiosystem HeartMate Registry. Wooster, MA,
Thermocardiosystems, 2000.
70.
Sun B.C., Catanese K.A., Spanier T.B., et al. 100 long-term
implantable left ventricular assist devices: the Columbia
Presbyterian interim experience. Ann Thorac Surg. 1999;68:688-694.
71.
Bourge R.C., Kirklin J.K., Naftel D.C., White C., Mason
D.A., Epstein A.E. Analysis and predictors of pulmonary
vascular resistance after cardiac transplantation. J
Thorac Cardiovasc Surg. 1991;101:432-444.
72.
Fukamachi K., McCarthy P.M., Smedira N.G., Vargo R.L.,
Starling R.C., Young J.B. Preoperative risk factors
for right ventricular failure after implantable left
ventricular assist device insertion. Ann Thorac Surg.
1999;68:2181-2184.
73.
Kormos RL, Gasior T.A., Kawai A., et al. Transplant
candidate’s clinical status rather than right
ventricular function defines need for univentricular
versus biventricular support. J Thorac Cardiovasc Surg.
1996;111:773-782.
74.
Oz M.C., Rose E.A., Levin H.R. Selection criteria for
placement of left ventricular assist devices. Am Heart
J. 1995;129:173-177.
75.
Bethesda Conference: conference for the design of clinical
trials to study circulatory support devices for chronic
heart failure. Ann Thorac Surg. 1998;66:1452-1465.
76.
Moskowitz A.J., Weinberg A.D., Oz M.C., Williams D.L.
Quality of life with an implanted left ventricular assist
device. Ann Thorac Surg. 1997;64:1764-1769.
77.
Stevenson L.W., Couper G., Natterson B., et al. Target
heart failure populations for newer therapies. Circulation.
1995;92:II174-II181.
78.
Byock I.R., Merriman M.P. Measuring quality of life
for patients with terminal illness: the Missoula-VITAS
quality of life index. Palliat Med. 1998;12:231-244.
79.
Levenson J.W., McCarthy E.P., Lynn J., Davis R.B., Phillips
R.S. The last six months of life for patients with congestive
heart failure. J Am Geriatr Soc. 2000;48:S101-S109.
80.
Food, Drug, and Cosmetic Act. 501–21. 2000.
81.
Grage T.J., Zelen M. The controlled randomized clinical
trial in the evaluation of cancer treatment—the
dilemma and alternative trial design. UICC Tech Rep
Ser. 1982;70:20-46.
82.
Freedman B. Equipoise and the ethics of clinical research.
N Engl J Med. 1987;317:141-145.
83.
Hellman S., Hellman D.S. Of mice but not men. Problems
of the randomized clinical trial. N Engl J Med. 1991;324:1585-1589.
84.
Passamani E. Clinical trials—are they ethical?.
N Engl J Med. 1991;324:1589-1592.
85.
Marquis D. How to resolve an ethical dilemma concerning
randomized clinical trials. N Engl J Med. 1999;341:691-693.
86.
Crispell K., Nauman D., Walker T., et al. Outpatient
continuous inotropic therapy with end stage heart failure:
palliative or life-prolonging?. J Card Fail. 1998;4:39
87.
Parker L.S., Arnold R.M., Meisel A., Siminoff L.A.,
Roth L.H. Ethical factors in the allocation of experimental
medical therapies: the chronic left ventricular assist
system. Clin Res. 1990;38:537-544.
88.
Torgerson D.J., Sibbald B. Understanding controlled
trials. What is a patient preference trial?. BMJ. 1998;316:360
89.
Lambert M.F., Wood J. Incorporating patient preferences
into randomized trials. J Clin Epidemiol. 2000;53:163-166.
90.
Brewin C.R., Bradley C. Patient preferences and randomised
clinical trials. BMJ. 1989;299:313-315.
91.
McPherson K., Britton A.R., Wennberg J.E. Are randomized
controlled trials controlled? Patient preferences and
unblind trials. J R Soc Med. 1997;90:652-656.
92.
Volberding P.A., Lagakos S.W., Koch M.A., et al. Zidovudine
in asymptomatic human immunodeficiency virus infection.
A controlled trial in persons with fewer than 500 CD4-positive
cells per cubic millimeter. The AIDS Clinical Trials
Group of the National Institute of Allergy and Infectious
Diseases. N Engl J Med. 1990;322:941-949.
93.
Kern M.J., Cohen M., Talley J.D., et al. Early ambulation
after 5 French diagnostic cardiac catheterization: results
of a multicenter trial. J Am Coll Cardiol. 1990;15:1475-1483.
94.
Benson K., Hartz A.J. A comparison of observational
studies and randomized, controlled trials. N Engl J
Med. 3422000:1878-1886.
95.
Concato J., Shah N., Horwitz R.I. Randomized, controlled
trials, observational studies, and the hierarchy of
research designs. N Engl J Med. 2000;342:1887-1892.
96.
Pocock S.J., Elbourne D.R. Randomized trials or observational
tribulations?. [editorial comment] N Engl J Med. 2000;342:1907-1909.
97.
Califf R.M., Adams K.F., McKenna W.J., et al. A randomized
controlled trial of epoprostenol therapy for severe
congestive heart failure: the Flolan International Randomized
Survival Trial (FIRST). Am Heart J. 1997;134:44-54.
98.
Cuffe M.S., Califf R.M., Adams K.F., et al. Rationale
and design of the OPTIME CHF trial: outcomes of a prospective
trial of intravenous milrinone for exacerbations of
chronic heart failure. Am Heart J. 2000;139:15-22.
99.
Finkelstein M.O., Levin B., Robbins H. Clinical and
prophylactic trials with assured new treatment for those
at greater risk: I. A design proposal. Am J Public Health.
1996;86:691-695.
100.
Pantalos G.M., Altieri F., Berson A., et al. Long-term
mechanical circulatory support system reliability recommendation:
American Society for Artificial Internal Organs and
The Society of Thoracic Surgeons: long-term mechanical
circulatory support system reliability recommendation.
Ann Thorac Surg. 1998;66:1852-1859.
101.
Butler K., Thomas D., Antaki J., et al. Development
of the Nimbus/Pittsburgh axial flow left ventricular
assist system. Artif Organs. 1997;21:602-610.
102.
Marlinski E., Jacobs G., Deirmengian C., Jarvik R. Durability
testing of components for the Jarvik 2000 completely
implantable axial flow left ventricular assist device.
ASAIO J. 1998;44:M741-M744.
103.
Kaplon R.J., Oz M.C., Kwiatkowski P.A., et al. Miniature
axial flow pump for ventricular assistance in children
and small adults. J Thorac Cardiovasc Surg. 1996;111:13-18.
104.
Wieselthaler G.M., Schima H., Hiesmayr M., et al. First
clinical experience with the DeBakey VAD continuous-axial-flow
pump for bridge to transplantation. Circulation. 2000;101:356-359.
105.
Clark R.E., Walters R.A., Hughson S., Davis S.A. Sr.,
Magovern G.J. Left ventricular support with the implantable
AB-180 centrifugal pump in sheep with acute myocardial
infarction. ASAIO J. 1998;44:804-811.
106.
Griffin W.P., Savage E.B., Clark R.E., et al. AB-180
circulatory support system: summary of development and
phase I clinical trial. ASAIO J. 1998;44:M719-M724.
107.
Farrar D.J., Buck K.E., Coulter J.H., Kupa E.J. Portable
pneumatic biventricular driver for the Thoratec ventricular
assist device. ASAIO J. 1997;43:M631-M634.
108.
Farrar D.J., K-rfer R., El Banayosy A., Posival H.,
Loisance D.Y., Tixier D. First clinical use of the Thoratec
TLC-II portable VAD driver in ambulatory and patient
discharge settings. ASAIO J. 1998;44:35A
109.
Weiss W.J., Rosenberg G., Snyder A.J., et al. A completely
implanted left ventricular assist device. Chronic in
vivo testing. ASAIO J. 1993;39:M427-M432.
110.
Kung R.T., Yu L.S., Ochs B., Parnis S., Frazier O.H.
An atrial hydraulic shunt in a total artificial heart.
A balance mechanism for the bronchial shunt. ASAIO J.
1993;39:M213-M217.
111.
Weiss W.J., Rosenberg G., Snyder A.J., et al. Steady
state hemodynamic and energetic characterization of
the Penn State/3M Health Care Total Artificial Heart.
ASAIO J. 1999;45:189-193.
|
